The STRIDER trials: ongoing research

Wessel Ganzevoort* (Corresponding Author), Christian Gluud, Ken Lim, Ben Mol, Katie Groom

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)e3
Number of pages1
JournalThe Lancet Child and Adolescent Health
Issue number3
Early online date13 Feb 2018
Publication statusPublished - Mar 2018

Bibliographical note

Refers to:

Andrew Sharp, Christine Cornforth, Richard Jackson, Jane Harrold, Mark A Turner, Louise C Kenny, Philip N Baker, Edward D Johnstone, Asma Khalil, Peter von Dadelszen, Aris T Papageorghiou, Zarko Alfirevic

Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial

The Lancet Child & Adolescent Health, Volume 2, Issue 2, February 2018, Pages 93-102

Cite this